Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors-Reference-Cited by-同舟云学术

Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors

Published:2022-04 Issue:6 Volume:14 Page:389-393
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Serra Francesco¹²,Cassaniti Irene³,Lilleri Daniele³,Pedrazzoli Paolo¹²,Baldanti Fausto³⁴,Lasagna Angioletta¹^ORCID

Affiliation:

1. Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy

2. Dept. of Internal Medicine & Medical Therapy, University of Pavia, Pavia, 27100, Italy

3. Molecular Virology Unit, Dept. of Microbiology & Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy

4. Dept. of Clinical, Surgical, Diagnostic & Pediatric Sciences, University of Pavia, Pavia, 27100, Italy

Abstract

Tweetable abstract Herpes zoster (HZ) is a vaccine-preventable disease, but the role of the vaccine in cancer patients during immunotherapy (ICIs) is still unknown. The clinical and economic consequences of HZ and the increased use of ICIs require a greater awareness by the oncologist.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2021-0333

Reference36 articles.

1. Zeroing in on zoster: A tale of many disorders produced by one virus

2. Herpes Zoster Presentation, Management, and Prevention: A Modern Case-Based Review

3. Risk of Herpes Zoster in Cancer Patients and the Promise of New Vaccines

4. The Association between Herpes Zoster and Increased Cancer Risk: A Nationwide Population-Based Matched Control Study

5. Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination;Vaccines;2024-02-28

2. The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy;Human Vaccines & Immunotherapeutics;2023-12

3. A case report of pulmonary nocardiosis during pembrolizumab: the emerging challenge of the infections on immunotherapy;Immunotherapy;2022-12

4. Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM);ESMO Open;2022-08

5. Infectious complications and immunotherapy: old pitfalls and new horizons;Future Oncology;2022-07